SEC 13F Intelligence

Kanawha Capital Management LLC / ABBV

Kanawha Capital Management LLC’s Abbvie Inc Position

Does Kanawha Capital Management LLC own Abbvie Inc (ABBV)? Yes141.8K shares worth $31M (+2.17% of its 13F portfolio) as of Q1 2026, down from 142.1K shares the prior filed quarter.

Position Value
$31M
Q1 2026
Shares
141.8K
% of Portfolio
+2.17%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $14MQ4 ’18Q1 ’19: $12MQ2 ’19: $11MQ3 ’19: $11MQ4 ’19: $14MQ4 ’19Q1 ’20: $12MQ2 ’20: $16MQ3 ’20: $14MQ4 ’20: $17MQ4 ’20Q1 ’21: $17MQ2 ’21: $18MQ3 ’21: $17MQ4 ’21: $21MQ4 ’21Q1 ’22: $25MQ2 ’22: $24MQ3 ’22: $20MQ4 ’22: $24,539Q4 ’22Q1 ’23: $24MQ2 ’23: $20MQ3 ’23: $22MQ4 ’23: $22MQ4 ’23Q1 ’24: $26MQ2 ’24: $26MQ3 ’24: $28MQ4 ’24: $26MQ4 ’24Q1 ’25: $30MQ2 ’25: $27MQ3 ’25: $33MQ4 ’25: $32MQ4 ’25Q1 ’26: $31Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026141.8K$31M+2.17%
Q4 2025142.1K$32M+2.24%
Q3 2025143.1K$33M+2.29%
Q2 2025144.5K$27M+1.99%
Q1 2025144.0K$30M+2.34%
Q4 2024144.1K$26M+2.01%
Q3 2024142.4K$28M+2.04%
Q2 2024148.8K$26M+2.00%
Q1 2024142.1K$26M+2.07%
Q4 2023141.7K$22M+2.01%
Q3 2023150.6K$22M+2.17%
Q2 2023151.8K$20M+1.88%
Q1 2023152.1K$24M+2.32%
Q4 2022151.8K$24,539+2.41%
Q3 2022152.3K$20M+2.23%
Q2 2022153.8K$24M+2.39%
Q1 2022155.6K$25M+2.22%
Q4 2021155.3K$21M+1.78%
Q3 2021158.5K$17M+1.58%
Q2 2021159.1K$18M+1.64%
Q1 2021159.4K$17M+1.68%
Q4 2020161.8K$17M+1.78%
Q3 2020160.9K$14M+1.62%
Q2 2020160.7K$16M+1.95%
Q1 2020159.8K$12M+1.78%
Q4 2019157.8K$14M+1.63%
Q3 2019148.2K$11M+1.46%
Q2 2019147.3K$11M+1.43%
Q1 2019151.2K$12M+1.71%
Q4 2018154.7K$14M+2.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kanawha Capital Management LLC’s full portfolio or all institutional holders of ABBV.